United States · Investor

Iroquois Capital

Last cheque observed Feb 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $228M, Jul 2019Hedge fund

VentureGrowthSeedFarmers MarketFarmingVenture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 20 on record
Since the last cheque5008days00hrs00min00sec
Median round$5.7MRounds led0 of 20Sole investor3 roundsExits4 from the portfolioMostly inUnited States, 84%
Pitch Iroquois Capital

Iroquois Capital highlights

  1. 01

    20 rounds on record

  2. 02

    Mostly Venture and Growth: 90% of its rounds

  3. 03

    Sole investor in 3 rounds, median $1.3M

  4. 04

    4 exits from the portfolio

What they do

Type
Hedge fund (from a list, unverified)
Cheque size
Not stated
Sectors
Farmers MarketFarmingVenture Capital & Private Equity
Based in
Scottsdale, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first20 appearances

  1. 2013

    1 round

  2. Feb
    Covenant Surgical PartnersSeries C · US · pevc.dowjones.com$35MWith 2 others
  3. 2010

    10 rounds

  4. Sept
    OncothyreonGrowth · US · ir.oncothyreon.com$15MWith 10 others
  5. Aug
    Raptor PharmaceuticalsVenture · US · ir.raptorpharma.com$15MWith 4 others
  6. Jul
    SoligenixVenture · US$5.9MWith 8 others
  7. Jun
    TapImmuneVenture · US$1.3MSole investor
  8. Jun
    SoligenixVenture · US · dorbiopharma.com$5.2MWith 8 others
  9. May
    TapImmuneVenture · US$866KSole investor
  10. Mar
    Senesco TechnologiesVenture · US · senesco.com$12MWith 13 others
  11. Mar
    BiomodaVenture · US$1.0MWith 2 others
  12. Feb
    SinoHubVenture · CN$4.6MWith 9 others
  13. Feb
    VeriTeQ CorporationVenture · US$1.5MWith 1 other
  14. 2009

    3 rounds

  15. Aug
    CEL-SCIVenture · US · cel-sci.com$4.4MWith 6 others
  16. Aug
    AgenusVenture · US · antigenics.com$10MWith 2 others
  17. Jul
    Seed · deals.venturebeat.com$5.5MWith 20 others
  18. 2007

    1 round

  19. Jan
    ACE*COMMGrowth · US$5.0MWith 7 others
  20. 2006

    2 rounds

  21. Nov
    EUSA PharmaVenture · GB$19MWith 15 others
  22. Mar
    Migo SoftwareVenture · US$4.0MSole investor
  23. 2005

    3 rounds

  24. Dec
    EUSA PharmaVenture · GB$13MWith 4 others
  25. Aug
    BravoSolutionVenture · US$6.5MWith 12 others
  26. Jul
    PharmacopeiaVenture · US$7.6MWith 9 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration4 named

JNJoshua N. SilvermanManaging Member of the General Partner and the Investment ManageriFiling they signed
KKKimberly K. PageManaging Member of the General Partner and the Investment ManageriFiling they signed
RKRichard K. AbbeManaging Member of the General Partner and the Investment ManageriFiling they signed
SJScott J. CohenManaging Member of General PartneriFiling they signed

We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

OncothyreonListed$10MMay 2013
EUSA PharmaBought by Jazz Pharmaceuticals$650MApr 2012
PharmacopeiaBought by Ligand Pharmaceuticals$73MSept 2008
EUSA PharmaBought by EUSA Pharma$23MMar 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Iroquois Capital. A count of rooms they were both in, not a relationship either has claimed.

Downsview CapitalVC firm8rounds togetherHeights Capital ManagementInvestment firm5rounds togetherHighbridge Capital ManagementVC firm5rounds togetherHudson Bay Capital ManagementAsset manager5rounds togetherRamiusHedge fund5rounds togetherAlpha CapitalPrivate equity4rounds togetherDAFNA Capital Management, LLCWealth manager4rounds togetherNite Capital ManagementVC firm4rounds togetherRockmore CapitalVC firm3rounds togetherWhalehaven Capital FundVC firm3rounds togetherBristol Capital Advisors, LLCInvestment firm2rounds togetherChestnut Ridge CapitalInvestment firm2rounds together

Quick answers about Iroquois Capital

What does Iroquois Capital invest in?

Iroquois Capital invests most often at Venture and Growth (90% of the rounds on record), in sectors such as Farmers Market, Farming and Venture Capital & Private Equity.

How active is Iroquois Capital?

20 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2013.

How big are Iroquois Capital's cheques?

The median round it joins is $5.7M.

Does Iroquois Capital lead rounds?

Rarely, if at all: none of its 20 investments on record names it as the lead.

Where does Iroquois Capital invest?

Most of the companies it backs are in the United States (84%), the United Kingdom (11%) and China (5%).

Is Iroquois Capital investing now?

No investments in the last 12 months; the latest was in Feb 2013.

Who does Iroquois Capital invest alongside?

Most often Downsview Capital (8 rounds together), Heights Capital Management (5 rounds together) and Highbridge Capital Management (5 rounds together).

What kind of investor is Iroquois Capital?

Iroquois Capital is a hedge fund based in Scottsdale, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it